StockData
Vivani Medical, Inc. logo

Vivani Medical, Inc. (VANI) stock

VANINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.05+0.00 (0.00%)

Close on Nov 18, 2026Market cap $94.71MP/E –Yield –

Vivani Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Vivani Medical's operating income for the twelve months ending Jun 30, 2026 was -$27.23M. For fiscal 2025 it was -$27.56M. The highest annual figure on record is -$13.32M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$27.56M–
FY2024Dec 31, 2024-$24.68M–
FY2023Dec 31, 2023-$26.97M–
FY2022Dec 31, 2022-$21.24M–
FY2021Dec 31, 2021-$13.32M–
FY2020Dec 31, 2020-$14.90M–
FY2019Dec 31, 2019-$33.95M–
FY2018Dec 31, 2018-$35.18M–
FY2017Dec 31, 2017-$28.61M–
FY2016Dec 31, 2016-$33.21M–
FY2015Dec 31, 2015-$20.05M–
FY2014Dec 31, 2014-$21.23M–
FY2013Dec 31, 2013-$18.00M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.87M–
Q1 FY2026Mar 31, 2026-$6.82M–
Q4 FY2025Dec 31, 2025-$6.81M–
Q3 FY2025Sep 30, 2025-$6.73M–
Q2 FY2025Jun 30, 2025-$7.46M–
Q1 FY2025Mar 31, 2025-$6.56M–
Q4 FY2024Dec 31, 2024-$6.46M–
Q3 FY2024Sep 30, 2024-$6.31M–
Q2 FY2024Jun 30, 2024-$5.68M–
Q1 FY2024Mar 31, 2024-$6.23M–
Q4 FY2023Dec 31, 2023-$6.22M–
Q3 FY2023Sep 30, 2023-$7.14M–
Q2 FY2023Jun 30, 2023-$7.00M–
Q1 FY2023Mar 31, 2023-$6.60M–
Q4 FY2022Dec 31, 2022-$7.79M–
Q3 FY2022Sep 30, 2022-$5.44M–
Q2 FY2022Jun 30, 2022-$4.09M–
Q1 FY2022Mar 31, 2022-$3.91M–
Q4 FY2021Dec 31, 2021-$1.29M–
Q3 FY2021Sep 30, 2021-$3.49M–
Q2 FY2021Jun 30, 2021-$2.30M–
Q1 FY2021Mar 31, 2021-$2.84M–
Q4 FY2020Dec 31, 2020-$1.27M–
Q3 FY2020Sep 30, 2020-$1.60M–
Q2 FY2020Jun 30, 2020-$3.12M–
Q1 FY2020Mar 31, 2020-$8.90M–
Q4 FY2019Dec 31, 2019-$8.13M–
Q3 FY2019Sep 30, 2019-$7.62M–
Q2 FY2019Jun 30, 2019-$8.44M–
Q1 FY2019Mar 31, 2019-$9.77M–
Q4 FY2018Dec 31, 2018-$8.88M–
Q3 FY2018Sep 30, 2018-$8.55M–
Q2 FY2018Jun 30, 2018-$7.99M–
Q1 FY2018Mar 31, 2018-$9.77M–
Q4 FY2017Dec 31, 2017-$7.43M–
Q3 FY2017Sep 30, 2017-$6.75M–
Q2 FY2017Jun 30, 2017-$6.87M–
Q1 FY2017Mar 31, 2017-$7.56M–
Q4 FY2016Dec 31, 2016-$10.38M–
Q3 FY2016Sep 30, 2016-$8.50M–

More Vivani Medical figures

See a number that looks wrong?